Market Closed -
Bombay S.E.
12:18:33 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
170.6
INR
|
-1.02%
|
|
-0.98%
|
+5.95%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,254
|
2,473
|
1,209
|
3,882
|
6,376
|
10,579
|
Enterprise Value (EV)
1 |
5,125
|
3,097
|
1,789
|
4,106
|
6,152
|
10,809
|
P/E ratio
|
5.27
x
|
7.91
x
|
3.59
x
|
15.9
x
|
19.5
x
|
18.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.51
x
|
1.17
x
|
0.49
x
|
1.44
x
|
1.78
x
|
2.51
x
|
EV / Revenue
|
3.03
x
|
1.46
x
|
0.73
x
|
1.52
x
|
1.72
x
|
2.57
x
|
EV / EBITDA
|
9.91
x
|
5.52
x
|
2.83
x
|
5.16
x
|
10.2
x
|
12.7
x
|
EV / FCF
|
55.3
x
|
28.8
x
|
-50.1
x
|
15.4
x
|
14.9
x
|
-81.2
x
|
FCF Yield
|
1.81%
|
3.47%
|
-2%
|
6.51%
|
6.69%
|
-1.23%
|
Price to Book
|
5.27
x
|
2.21
x
|
0.83
x
|
1.67
x
|
2.27
x
|
2.96
x
|
Nbr of stocks (in thousands)
|
51,784
|
51,784
|
51,784
|
62,359
|
62,359
|
65,184
|
Reference price
2 |
82.15
|
47.75
|
23.35
|
62.25
|
102.2
|
162.3
|
Announcement Date
|
8/8/18
|
9/5/19
|
12/5/20
|
9/4/21
|
9/3/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,692
|
2,116
|
2,467
|
2,704
|
3,575
|
4,208
|
EBITDA
1 |
517.1
|
560.8
|
631.2
|
795.2
|
606.1
|
851.9
|
EBIT
1 |
397
|
436.9
|
501.5
|
645.4
|
466.4
|
703.8
|
Operating Margin
|
23.47%
|
20.64%
|
20.33%
|
23.87%
|
13.05%
|
16.72%
|
Earnings before Tax (EBT)
1 |
806.9
|
312.7
|
336.6
|
533.8
|
451.6
|
742.3
|
Net income
1 |
806.9
|
312.7
|
336.6
|
218.8
|
326.9
|
550.8
|
Net margin
|
47.7%
|
14.77%
|
13.64%
|
8.09%
|
9.14%
|
13.09%
|
EPS
2 |
15.58
|
6.038
|
6.500
|
3.921
|
5.240
|
8.570
|
Free Cash Flow
1 |
92.61
|
107.4
|
-35.72
|
267.1
|
411.7
|
-133.1
|
FCF margin
|
5.47%
|
5.08%
|
-1.45%
|
9.88%
|
11.51%
|
-3.16%
|
FCF Conversion (EBITDA)
|
17.91%
|
19.15%
|
-
|
33.59%
|
67.92%
|
-
|
FCF Conversion (Net income)
|
11.48%
|
34.35%
|
-
|
122.05%
|
125.93%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/8/18
|
9/5/19
|
12/5/20
|
9/4/21
|
9/3/22
|
9/5/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
871
|
625
|
580
|
224
|
-
|
230
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
225
|
-
|
Leverage (Debt/EBITDA)
|
1.685
x
|
1.114
x
|
0.9181
x
|
0.2813
x
|
-
|
0.2699
x
|
Free Cash Flow
1 |
92.6
|
107
|
-35.7
|
267
|
412
|
-133
|
ROE (net income / shareholders' equity)
|
282%
|
32.5%
|
26.1%
|
11.4%
|
12.5%
|
17%
|
ROA (Net income/ Total Assets)
|
10.7%
|
11.2%
|
12.1%
|
12.4%
|
7.52%
|
9.45%
|
Assets
1 |
7,551
|
2,803
|
2,783
|
1,759
|
4,349
|
5,828
|
Book Value Per Share
2 |
15.60
|
21.60
|
28.10
|
37.30
|
45.00
|
54.70
|
Cash Flow per Share
2 |
0.0900
|
0.6400
|
0.6500
|
1.680
|
1.940
|
0.8600
|
Capex
1 |
189
|
280
|
131
|
145
|
197
|
441
|
Capex / Sales
|
11.2%
|
13.23%
|
5.29%
|
5.36%
|
5.51%
|
10.48%
|
Announcement Date
|
8/8/18
|
9/5/19
|
12/5/20
|
9/4/21
|
9/3/22
|
9/5/23
|
|
1st Jan change
|
Capi.
|
---|
| +6.82% | 149M | | +5.14% | 103B | | -1.80% | 63.04B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|